Platform
DefiniGEN Opti-HEP
Applications
Efficacy Screening
Hit to Lead
Lead Optimization
Toxicology Screening
Disease Modeling
Knock-In Cell Line Service
Knock-Out Cell Line Service
Models
PFIC2
MASLD
A1ATD
Wilson's Disease
Ornithine transcarbamylase deficiency
Cells
Opti-HEP (WT)
Intestinal Organoids
About
About us
Career Opportunities
News
News
Blog
Events
View all events
Resources
Resources
Blogs
Contact
Platform
DefiniGEN Opti-HEP
Applications
Efficacy Screening
Hit to Lead
Lead Optimization
Toxicology Screening
Disease Modeling
Knock-In Cell Line Service
Knock-Out Cell Line Service
Models
PFIC2
MASLD
A1ATD
Wilson's Disease
Ornithine transcarbamylase deficiency
Cells
Opti-HEP (WT)
Intestinal Organoids
About
About us
Career Opportunities
News
News
Blog
Events
View all events
Resources
Resources
Blogs
Contact
ASGCT 2024
7-11 May 2024 / Baltimore, MD, United States
Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP):
Can be applied to any modality;
Is engineered to recapitulate disease phenotypes; and
Offers diverse genetic backgrounds for screening.